Cargando…

Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom

Introduction Malignant melanoma (MM) is potentially a fatal type of skin cancer and a major health concern for the Caucasian population. It is a heterogeneous disease with a wide spectrum of manifestations. Therefore, in this study, we evaluated the clinicopathological characteristics of MM. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Haroon, Saroona, Vithanage, Iresha, Rashid, Khushbakht, Aslam, Mahnoor, Elmahdy, Heba, Zia, Shamail, Malik, Umair Arshad, Irfan, Muhammad, Hashmi, Atif A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315104/
https://www.ncbi.nlm.nih.gov/pubmed/37404434
http://dx.doi.org/10.7759/cureus.39874
_version_ 1785067444333707264
author Haroon, Saroona
Vithanage, Iresha
Rashid, Khushbakht
Aslam, Mahnoor
Elmahdy, Heba
Zia, Shamail
Malik, Umair Arshad
Irfan, Muhammad
Hashmi, Atif A
author_facet Haroon, Saroona
Vithanage, Iresha
Rashid, Khushbakht
Aslam, Mahnoor
Elmahdy, Heba
Zia, Shamail
Malik, Umair Arshad
Irfan, Muhammad
Hashmi, Atif A
author_sort Haroon, Saroona
collection PubMed
description Introduction Malignant melanoma (MM) is potentially a fatal type of skin cancer and a major health concern for the Caucasian population. It is a heterogeneous disease with a wide spectrum of manifestations. Therefore, in this study, we evaluated the clinicopathological characteristics of MM. Methods We retrospectively studied the clinicopathological characteristics of MM in 167 biopsy-proven cases of MM reported between January 2020 and December 2021 at Kings Mill Hospital, Sutton-in-Ashfield, United Kingdom. Clinical data such as the age, sex, and anatomical site of the lesion were obtained from the clinical referral forms. Biopsies of the lesions were performed, and the specimens collected were sent to the laboratory for histopathological study and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutation evaluation. Formalin-fixed paraffin-embedded blocks (FFPE) were prepared, sectioned, and stained with hematoxylin and eosin for histological examination. Results A total of 167 cases of MM were included in the study. The age range was 23-96 years, with the median age at diagnosis found to be 66 years; males were more commonly affected (52.1%). The median Breslow thickness was 1.20 mm. The median mitotic activity was 1.0/mm(2). The lower limb was the most common site of involvement (27.5%), followed by the thorax (25.1%). The most common histological subtype was superficial spreading melanoma (SSM) (77.8%), followed by nodular melanoma (14.4%). The in situ component was present in 95.8% of cases; a majority (92.2%) of the cases showed vertical growth phase, 71.9% of cases were at Clark’s level IV of invasion, regression was noted in 70.7% of cases, ulceration was present in 21.6% of cases, and microsatellites were present in 3% of cases. Perineural invasion was present in 3% of cases, and lymphovascular invasion (LVI) was present in 4.2% of cases. BRAF mutation testing was performed on 36 cases, out of which 20 cases (55.6%) showed BRAF mutation. Acral lentiginous melanoma and nodular melanoma were most likely to show ulceration (66.7% and 37.5%, respectively). SSM and lentigo maligna melanoma were more likely to be associated with regression. Conclusion The study demonstrated that MM is prevalent among the elderly population with male predominance; SSM was found to be the most common subtype. The study further demonstrated various clinicopathological features of MM and its association with histological subtypes.
format Online
Article
Text
id pubmed-10315104
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103151042023-07-03 Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom Haroon, Saroona Vithanage, Iresha Rashid, Khushbakht Aslam, Mahnoor Elmahdy, Heba Zia, Shamail Malik, Umair Arshad Irfan, Muhammad Hashmi, Atif A Cureus Dermatology Introduction Malignant melanoma (MM) is potentially a fatal type of skin cancer and a major health concern for the Caucasian population. It is a heterogeneous disease with a wide spectrum of manifestations. Therefore, in this study, we evaluated the clinicopathological characteristics of MM. Methods We retrospectively studied the clinicopathological characteristics of MM in 167 biopsy-proven cases of MM reported between January 2020 and December 2021 at Kings Mill Hospital, Sutton-in-Ashfield, United Kingdom. Clinical data such as the age, sex, and anatomical site of the lesion were obtained from the clinical referral forms. Biopsies of the lesions were performed, and the specimens collected were sent to the laboratory for histopathological study and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutation evaluation. Formalin-fixed paraffin-embedded blocks (FFPE) were prepared, sectioned, and stained with hematoxylin and eosin for histological examination. Results A total of 167 cases of MM were included in the study. The age range was 23-96 years, with the median age at diagnosis found to be 66 years; males were more commonly affected (52.1%). The median Breslow thickness was 1.20 mm. The median mitotic activity was 1.0/mm(2). The lower limb was the most common site of involvement (27.5%), followed by the thorax (25.1%). The most common histological subtype was superficial spreading melanoma (SSM) (77.8%), followed by nodular melanoma (14.4%). The in situ component was present in 95.8% of cases; a majority (92.2%) of the cases showed vertical growth phase, 71.9% of cases were at Clark’s level IV of invasion, regression was noted in 70.7% of cases, ulceration was present in 21.6% of cases, and microsatellites were present in 3% of cases. Perineural invasion was present in 3% of cases, and lymphovascular invasion (LVI) was present in 4.2% of cases. BRAF mutation testing was performed on 36 cases, out of which 20 cases (55.6%) showed BRAF mutation. Acral lentiginous melanoma and nodular melanoma were most likely to show ulceration (66.7% and 37.5%, respectively). SSM and lentigo maligna melanoma were more likely to be associated with regression. Conclusion The study demonstrated that MM is prevalent among the elderly population with male predominance; SSM was found to be the most common subtype. The study further demonstrated various clinicopathological features of MM and its association with histological subtypes. Cureus 2023-06-02 /pmc/articles/PMC10315104/ /pubmed/37404434 http://dx.doi.org/10.7759/cureus.39874 Text en Copyright © 2023, Haroon et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Haroon, Saroona
Vithanage, Iresha
Rashid, Khushbakht
Aslam, Mahnoor
Elmahdy, Heba
Zia, Shamail
Malik, Umair Arshad
Irfan, Muhammad
Hashmi, Atif A
Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom
title Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom
title_full Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom
title_fullStr Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom
title_full_unstemmed Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom
title_short Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom
title_sort clinicopathological profile of a cohort of patients with malignant melanoma in the united kingdom
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315104/
https://www.ncbi.nlm.nih.gov/pubmed/37404434
http://dx.doi.org/10.7759/cureus.39874
work_keys_str_mv AT haroonsaroona clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom
AT vithanageiresha clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom
AT rashidkhushbakht clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom
AT aslammahnoor clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom
AT elmahdyheba clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom
AT ziashamail clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom
AT malikumairarshad clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom
AT irfanmuhammad clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom
AT hashmiatifa clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom